What is Dyne Therapeutics, Inc.'s interest expense?

Dyne Therapeutics, Inc. (DYN) reported interest expense of $4.2M in Q1 2026.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Dyne Therapeutics, Inc. DYN Interest Expense

Interest Expense at other companies

Ionis PharmaceuticalsIONS

$5.16M+25.6%

Arrowhead ResearchARWR

$23.85M+10.2%

PTC TherapeuticsPTCT

-$49.03M-43.8%

Scholar RockSRRK

$2.3M+26.6%

Cogent Biosciences, Inc.COGT

$1.21M—

Krystal Biotech, Inc.KRYS

$7.75M+5.6%

Other financials

Income statement

See full

Operating income-$125.3M-2.4%

Net income-$120.9M-4.8%

EPS (diluted)-$0.73+30.5%

Balance sheet

See full

Cash & equivalents$753.1M+59.5%

Total debt$168.7M+623%

Total equity$865.1M+29.3%

Total assets$1.1B+49.8%

Cash flow

See full

Operating cash flow-$144.9M-36.9%

CapEx$221.0K-77.5%

Free cash flow-$145.1M-35.8%

Valuation

See full

Market cap$3.35B+153%

Returns & leverage

See full

Return on equity-58.9%-4.4pp

Debt / equity0.2×+0.2×

Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseOther.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s interest expense?: Dyne Therapeutics, Inc. (DYN) reported interest expense of $4.2M in Q1 2026.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.